46843-08-7Relevant articles and documents
triAZOLOtriAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
-
Page/Page column 100, (2020/01/24)
The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.